Skip to main content
. 2017 Aug 23;8(46):81462–81474. doi: 10.18632/oncotarget.20399

Table 1. Demographic and clinical parameters of the cohort.

Control (n = 71) Breast cancer (n = 77) p-value
Age (years) 44.0 ± 1.3 53.6 ± 1.2 < 0.001
Weight (kg) 67.9 ± 1.3 69.2 ± 1.2 0.480
BMI (kg/m2) 26.2 ± 0.5 26.9 ± 0.5 0.316
Systolic pressure (mm Hg) 112.7 ± 1.9 127.0 ± 2.6 < 0.001
Diastolic pressure (mm Hg) 69.7 ± 1.4 75.4 ± 1.8 0.034
Waist perimeter (cm) 86.3 ± 1.3 89.1 ± 1.4 0.160
Number of children 1.9 ± 0.09 2.3 ± 0.1 0.124
Age of menarche 12.3 ± 0.2 12.6 ± 0.1 0.241
Age of first childbirth 26.2 ± 0.7 25.0 ± 0.6 0.221
Premenopausal state (%) 77.0 55.0 0.001
Postmenopausal state (%) 23.0 45.0 0.001
Total cholesterol (mg/dL) 201.2 ± 4.4 210.6 ± 3.9 0.116
HDL cholesterol (mg/dL) 53.6 ± 1.5 53.8 ± 1.4 0.950
LDL cholesterol (mg/dL) 127.5 ± 3.7 134.6 ± 3.6 0.109

Values represent mean ± SEM of each parameter in control (n = 71) and breast cancer (n = 77) groups. P-value indicates differences by Mann-Whitney, Student t-test and/or Fisher exact test. p < 0.05 was considered significant.